References

 

  1. “Adult-Onset Diabetes Show Atherogenic Lipid Patterns.” Medical World News. P56, January 8, 1979.
  2. Aguilar-Bryan, L., Nichols, C.G., Wechsler, S.W., Clement, J.P., Boyd, A.E., Gonzalez, G., Herrera-Sosa, H.,
    Nguy, K., Bryan, J., and Nelson, D.A., Cloning of the ß-cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268:423- 426, 1995.
  3. American Diabetes Association, American Diabetes Association Complete Guide to Diabetes.Bantam, NY, 1996.
  1. Anderson, J.W., et al., “Beneficial Effects of a High Carbohydrate, High Fiber Diet on Hyperglycemic
    Diabetic Men.” American Journal of Clinical Nutrition 29:895-899, 1976.
  2. Anon, Health Foods Business 38(8):13, 1992.
  3. Awang, D.V.C., Canadian Pharmaceutical Journal 123: 121-126, 1990.
  4. Bamford, D.S., Percival, R.C., and Tothill, A.U., British Journal of Pharmacology 40:161P-162P, 1970.
  5. Barber, A.J., Pharmaceutical Journal 240:723-725, 1988.
  6. Baskaran, K., et al., Antidiabetic Effect of a Leaf Extract from Gymnema sylverstre in
    Non-Insulin Dependent Diabetes Mellitus Patients. J Ethnopharmacol 30:295-305, 1990.
  7. Beckett, A.H., Belthle, F.W., Fell, K.R., and Lockett, M.F., Journal of Pharmacy and Pharmacology
    6:785-796, 1954.
  8. Biometric Society, “Report of the Committee for Assessment of Biometric Aspects of Controlled Trials of the Hypoglycemic Agents.” Journal of the American Medical Association 231:583-608, 1975.
  9. Blumenthal, M., Health Foods Business 35(9):18, 104-105, 1989.
  10. Bosco, D., The People’s Guide to Vitamins and Minerals. Contemporary Books, Chicago, 1980.
  11. Bricklin, M., Encyclopedia of Natural Home Remedies. Rodale Press, Emmaus, Pennsylvania,
    pp.379-381, 1982.
  12. Briggs, C.J., Canadian Pharmaceutical Journal 119:248-254,1986.
  13. Bundesanzeiger (Cologne, Germany), May 15, 1985.
  14. Bundesanzeiger (Cologne, Germany), January 5, 1989.
  15. Burton, J., Lydia Pinkham is Her Name, Farrar, Straus, NY, p.107, 1949.
  16. Calvert, G.D., Medical World News, p56, January 8, 1979.
  17. Campbell, P., et al., “Pathogenesis of the Dawn Phenomenon in Patients with Insulin-Dependent Diabetes Mellitus.” New England Journal of Medicine 312:1473-1479, 1985.
  18. Castleman, M., The Healing Herbs. Rodale Press, Emmaus, Pennsylvania, 1991, pp.294-296.
  19. Chakravarthy B.K, Gupa S., and Gode K.D., Functional ß-Cell Regeneration in the Islets of Pancreas
    in Alloxan Induced Diabetic Rats by (-)-Epicatechin. Life Sci 31:2693-2697, 1982.
  20. Chakravarthy B.K., et al., Pancreatic ß-Cell Regeneration in Rats by (-)-Epicatechin. Lancet 2:759-760,
    1981.
  21. Chalmers, T.C., ed., “Settling the UGDE Controversy.” Journal of the American Medical Association 231:624-625, 1975.
  22. Colata, G., “How Important is Dietary Calcium in Preventing Osteoporosis.” Science 233:519-520, 1986.
  23. Cooper, W.D., “Cardiac Arrhythmias Following Acute Myocardial Infarction: Associations with the Serum Potassium Level and Prior Diuretic Therapy.” European Heart Journal 5:464, 1984.
  24. Cornfield, J., “The University Group Diabetes Program: A Further Study of the Mortality Finding.” Journal of the American Medical Association 217:1676-1687, 1971.
  25. Coustan, D.R., “A Randomized Clinical Trial of the Insulin Pump vs. Intensive Conventional Therapy in Diabetic Pregnancies.” Journal of the American Medical Association 255:631-636, 1986.
  26. Cryer, P.E., “Glucose Counterregulation, Hypoglycemia, and Intensive Insulin Therapy in Diabetes Mellitus.” New England Journal of Medicine 313:232-241, 1985.
  27. Davidson, J., Clinical Diabetes Mellitus, A Problem Oriented Approach. Thieme, Inc., NY, 1986.
  28. Davidson, J.K., “The FDA and Hypoglycemic Drugs.” Journal of the American Medical Association
    232:854, 1975.
  29. Davidson, M.B., Diabetes Mellitus, Diagnosis and Treatment, 2nd ed., John Wiley & Sons, NY, 1986.
  30. De Smet, P.A.G.M., Canadian Pharmaceutical Journal 124:5,1991.
  31. “Diabetes Diagnoses Grounded on GTT Are Wrong Most of Time.” Family Practice News: 1, October 15, 1979.
  32. Duker, E.-M., Kopanski, L., Jarry, H., and Wuttke, W., Planta Medica 57:420-424, 1991.
  33. Dupree, J., “Near Normal Glycemic Control Does Not Slow Progression of Mild Diabetic Retinopathy.”
    Paper presented to American Diabetes Association meeting, 1983.
  34. Earon, G., Stern, E., and Lavosky, H., Successful Use of Atriplex halimus in the Treatment of Type II
    Diabetic Patients. Controlled clinical research report on the subject of Atriplex. Unpublished study
    conducted at the Hebrew University of Jerusalem, Jerusalem, Israel, 1989.
  35. “Fish Oil May Ease Arthritis Pain.” Medical World News. July 14, 1986, p.9. General Practitioner Research Group, “Calcium Pantothenate in Arthritic Conditions.” Practitioner 224:208, 1980.
  36. Gonzalez, E.R., “Exercise Therapy Rediscovered for Diabetes, But What Does It Do?” Journal of the
    American Medical Association 242:1591, 1979.
  37. Goo, A.K., Carson, D.S., and Bjelajac, A., Metformin: a new treatment option for non-insulin-dependent
    diabetes mellitus. Journal of Family Practice 42:612-618, 1996.
  38. Greene, E-L., “Well-Being Up With Captopril, Down With Two Other Agents.” Medical Tribune, p8,
    September 17, 1986.
  39. Hadden, D.R., “Myocardial Infarction in Maturity-Onset Diabetes, A Retrospective Study.” Lancet
    1:335-338, 1972.
  40. Hansel, R., Phytopharmaka, 2nd ed., Springer-Verlag, Berlin, 1991, pp.223-230.
  41. Hendler, S.S., The Complete Guide of Anti-Aging Nutrients. Simon & Schuster, NY, 1985
  42. Himsworth, H.P., “The Dietetic Factor Determining the Glucose Tolerance and Sensitivity to Insulin of
    Healthy Men.” Clinical Science 2:67-94, 1935.
  43. Howes, L.G., Sundaresan, P., Lykos, D., Cardiovascular effects of oral hypoglycemic drugs. Clin. Exp.
    Pharm. Physiol. 23(3):201-206, 1966.
  44. Johnson, N.E., “Effect of Level of Protein Intake of Urinary and Fecal Calcium and Calcium Retention of Young Adult Males.” Journal of Nutrition 100:1425-1430, 1970.
  45. Kang, S.M., Traditional Korean Herbal Treatment for Diabetes. Hyungsul, Seoul, Korea, 1990
  46. Kempner, W., “Treatment of Hypertension Vascular Disease with Rice Diet.” American Journal of
    Medicine 4:545-577, 1948.
  47. Keye, W.R., Jr., “Premenstrual Syndrome (PMS)” in Conn’s Current Therapy, H.F., Conn and R.E. Rakel,
    eds., W.B. Saunders, Philadelphia, 1984, pp.1000-1003.
  48. Khoo, S.K., Munro, C., and Battistutta, D., Medical Journal of Australia 153:189-192, 1990.
  49. Kim, E.J., Choi, M.G., et al., Encyclopedic Knowledge on Diabetes,153
    Questions and Answers. Seoeum, Seoul, Korea, 1995.
  50. Klachko, D.M., et al., “Blood Glucose Levels During Walking in Normal and Diabetic Subjects.” Diabetes 21:89-100, 1972.
  51. Knatterud, G.L., et al., “Hypoglycemic Agents on Vascular Complications in Patients with Adult-Onset
    Diabetes.” Journal of the American Medical Association 240: 37-42, 1978.
  52. Koto, Y., New Treatment for Diabetes, Medical Journal, Osaka, Japan, 1994.
  53. Kuller, L.H., “Unexpected Effects of Treating Hypertension in Men with Electrocardiographic Abnormalities:  A Critical Analysis.” Circulation 73:114-123, 1986.
  54. Lauritzen, T., “Two-Year Experience with Continuous Subcutaneous Insulin Infusion in Relation to
    Retinopathy and Neuropathy.” Diabetes 34 [suppl.3]:74-79, 1985.
  55. Lawrence Review of Natural Products, March 1989.
  56. Lehmann-Willenbrock, E., and Riedel, H.H., Zentralblatt fur Gynakologie 110:611-618 1988.
  57. Lernmark, A., “Islet Cell Surface Antibodies in Juvenile Diabetes Mellitus.” New England Journal of
    Medicine 299:375-380, 1978.
  58. Leslie, R.D.G., ed., Cause of Diabetes, Genetic and Environmental Factors. John Wiley & Sons, West
    Sussex, England, 1993.
  59. Levey, Gerald S., and Roger F. Palmer, “Effect of Tolbutamide on Adenyl Cyclase in Rabbit and Human
    Heart and Contractility of Isolated Rabbit Atria.” Journal of Clinical Endocrinology 33:317-334, 1971.
  60. Lorenzi, Mara, and Michael Goldman, “Improved Diabetic Control and Retinopathy.” New England Journal of Medicine 308:1600, 1983.
  61. Lubbos, H., Miller, J.L., and Rose, L.I., Oral hypoglycemic agents in type II diabetes mellitus. American
    Family Physician . 52:2075-2078, 1995.
  62. Mada, Z., et al., Glucose-Lowering Effect of Fenugreek in Non-Insulin Dependent Diabetics.
    Eur J Clin Nutr 42:51-54, 1988.
  63. Mather, H.M., “Hypomagnesaemis in Diabetes.” Acta Clinica Chemica 95:235-242, 1979.
  64. Mazess, R.B., “Bone Mineral Content of North Alaskan Eskimos.” American Journal of Clinical Nutrition 27:916-925, 1974.
  65. McDougall, J., McDougall’s Medicine, A Challenging Second Opinion. New Century Press, Piscataway,
    New Jersey, 1985.
  66. Medical World News, p9, July 14, 1986.
  67. Merrimee, Thomas, et al., “Insulin Like Growth Factors, Studies in Diabetes With and Without Retinopathy.”
    New England Journal of Medicine 309:527-530, 1983.
  68. Mertz, W., “Effects and Metabolism of Glucose Tolerance Factor.” Nutrition Review 33:1929, 1975.
  69. Miranda, Perla M., and David L. Horwitz, “High-Fiber Diets in the Treatment of Diabetes Mellitus.”
    Annals of Internal Medicine 88:482-486, 1978.
  70. Mitch, William E., et al., “The Effects of a Keto Acid-Amino Acid Supplement to a Restricted Diet on the Progression of Chronic Renal Failure.” New England Journal of Medicine 311:623-629, 1984.
  71. Morgan, T.O., “Failure of Therapy to Improve Prognosis in Elderly Males with Hypertension.” Australia Medical Journal 2:27, 1980.
  72. Murray, M.T., Diabetes and Hypoglycemia, How You Can Benefit from Diet, Vitamins, Minerals, Herbs,
    Exercise and Other Natural Methods. Prima, Rocklin, CA, 1994.
  73. Murray, M.T., The Healing Power of Herbs, The Enlightened Persons’s Guide to the Wonders of Medicinal Plants, Rev.2nd ed., Prima, Rocklin, CA, 1995.
  74. Nelson, R., “Dysmenorrhea” in Conn’s Current Therapy, H.F. Conn and R.E. Rakel, eds. W.B. Saunders,
    Philadelphia, pp.999-1000, 1984.
  75. Nutrition Search, Inc., Nutrition Almanac. McGraw-Hill Paperbacks, NY, 1979.
  76. Parham, B., “What’s Wrong with Eating Meat?” Ananda Marga Publications, Denver, 1981.
  77. Peterson, L., Cardiovascular Rehabilitation: A Comprehensive Approach. Macmillan, NY, 1983.
  78. Phillipson, B.E., et al., “Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with Hypertriglyceridemia.” New England Journal of Medicine 312:1210-1216, 1985.
  79. Pogatsa, G. Potassium channels in the cardiovascular system. diabetes Res. Clin. Practice. 28:591-589, 1995.
  80. Rabinowitch, I.M., “Effects of the High Carbohydrate-Low Calorie Diet Upon Carbohydrate Tolerance in Diabetes Mellitus.” Canadian Medical Association Journal 33:136-144, 1935.
  81. Rabinowitch, I.M., “Experiences with a High Carbohydrate-Low Calorie Diet for the Treatment of Diabetes Mellitus.” Canadian Medical Association Journal 23:489-498, 1930.
  82. Rabinowitch, I.M., “The Present Status of the High Carbohydrate-Low Calorie Diet for the Treatment of Diabetes.” Canadian Medical Association Journal 26:141-148, 1932.
  83. Ribes, G., et al., Effects of Fenugreek Seeds on Endocrine Pancreatic Secretions in Dogs. Ann Nutr Metab 28: 37-43, 1984.
  84. Roberts, H.J., “Perspective on Vitamin E as Therapy.” Journal of the American Medical Association
    256:129, 1981.
  85. Rose, W.C., “Amino Acid Requirements of Man.” Journal of Biological Chemistry 217:997-1004, 1955.
  86. Rudman, D., “Megadose Vitamins. Use and Misuse (editorial).” New England Journal of Medicine
    309:488, 1983.
  87. Sackler, A.M., “On the Nonsense of Official Recommended Daily Allowances (RDAs).” Medical Tribune, p46, September 18, 1985.
  88. Sahelian, R., DHEA, A Practical Guide. Avery Publishing Group, NY, 1996.
  89. Samsum, W.D., “The Use of High Carbohydrate Diets in the Treatment of Diabetes Mellitus.” Journal of the American Medical Association 86:178-181, January 16, 1926.
  90. Saudek, C.D., Rubin, R.R., and Shump, C.S., The Johns Hopkins Guide to Diabetes for Today and
    Tomorrow. The Johns Hopkins University Press, Baltimore, 1997.
  91. Saw, D., Pitman, E., Maung, M., Savasatit, P., Wasserman, D., Yeung, C.K.,1996. Granulomatous hepatitis associated with glyburide. Digestive Dis. Sci.41(2):322-315.
  92. Schaumburg, H., “Sensory Neuropathy from Pyridoxine Abuse.” New England Journal of Medicine
    309:1445-1448, 1983.
  93. Schor, S., “The University Group Diabetes Program, A Statistician Looks at the Mortality Results.” Journal of the American Medical Association 217:1671-1675, 1971.
  94. Seifter, Eli, Ph.D., et al., “Impaired Wound Healing in Streptozotic Diabetes: Prevention by Supplementary Vitamin A.” Annals of Surgery 194:42-50, 1982.
  95. Seo, J.S., and Yoo, D.J., Encyclopedic Knowledge on Adult Disease, 505 Questions and Answers.
    Seoeum, Seoul, Korea,1996.
  96. Shanmugasundaram, E.R.B., et al., Use of Gymnema sylverstre Leaf Extract in the Control of Blood
    Glucose in Insulin-Dependent Diabetes Mellitus. J Ethnopharmacol 30:281-294, 1990.
  97. Sharma, K.K., et al., Antihyperglycemic Effect of Onion: Effect on Fasting Blood Sugar and Induced
    Hyperglycemia in Man. Indian J Med Res 65:422-429, 1977.
  98. Sharma, R.D., Raghuram T.C., and Rao N.S., Effect of Fenugreek Seeds on Blood Glucose and Serum
    Lipids in Type I Diabetes. Eur J Clin Nutr 44:301-306, 1990.
  99. Sharpe, G.R., and Farr, P.M., Lancet 335:1283,1990.
  100. Sheela, C.G., and Augusti K.T., Antidiabetic Effects of S-Allyl Cysteine Sulphoxide Isolated from Garlic
    (Allium sativum Linn.). Indian J. Exp Biol 30:523-526, 1992.
  101. Somogyi, M., Bulletin of the St. Louis Jewish Hospital Medical Staff, May 1951.
  102. Somogyi, M., “Dietary and Insulin Therapy of Diabetes.” Bulletin of the St. Louis Jewish Hospital Medical Staff:1-16, October 1949.
  103. Srikanta, S., “Islet-Cell Antibodies and BETA-Cell Function in Monozygotic Triplets and Twins Initially Discordant for Type I Diabetes Mellitus.” New England Journal of Medicine 308:322-325, 1983.
  104. Srivastava, Y., et al., Antidiabetic and Adaptogenic Properties of Momordica charantia Extract:
    An Experimental and Clinical Evaluation. Phytother Res 7:285-289, 1993.
  105. Stern, E., Successful Use of Atriplex halimus in the Treatment of Type II Diabetic Patients. A preliminary study. Unpublished study conducted at the Zamenhoff Medical Center, Tel Aviv, Israel, 1989.
  106. Strobl, J., and Thomas, J.A., “Chapter 66” in Modern Pharmacology, 3rd ed,. C.R. Craig and R.E. Stitzel,
    eds., Little, Brown, Boston, pp.882-884, 1990.
  107. Struthers, A.D., “Prior Thiazide Diuretic Treatment Increases Adrenaline-Induced Hypokalemia.” Lancet 1:1358, 1985.
  108. Sweeney, J.S., “Dietary Factors That Influence the Dextrose Tolerance Test.” Archives of Internal
    Medicine 40:818-830, 1927.
  109. Tan, G.H., and Nelson, R.L., Pharmacologic treatment options for non-insulin- dependent diabetes
    mellitus. Mayo Clinic Proceedings 71:763-768, 1996.
  110. The Extra Pharmacopoeia-Martindale, 24th ed., vol.1, The Pharmaceutical Press, London, p.614, 1958.
  111. The Kroc Collaborative Study Group, “Blood Glucose and the Evolution of Diabetic Retinopathy and the Albuminuria.” New England Journal of Medicine 311:1365-1372, 1984.
  112. The Kroc Collaborative Study Group, “Hopes for Whole Pancreas, Islet Cell Transplant Falter.” Internal Medicine News, September 1-14, 1986.
  113. Thomas, J.A., “Chapter 63” in Modern Pharmacology, 3rd ed., C.R. Craig and R.E. Stitzel, eds., Little,
    Brown, Boston, p.850, 1990. 
  114. “Tight Control Trial Needs More Diabetics.” Medical World News, p6, February 23, 1987.
  115. Tyler, V.E., Herbs of Choice, The Therapeutic Use of Phytomedicinals. Pharmaceutical Products Press, Binghamton, NY, 1994.
  116. “University Group Diabetes Program: A Study of the Effects of Hypoglycemic Agents on Vascular
    Complications in Patients with Adult-Onset Diabetes. 11. Mortality Results.” Diabetes 19 [Suppl.]:814,
    1970.
  117. “University Group Diabetes Program.” Journal of the American Medical Association 218:1400-1410,
    1971.
  118. Walker, R., “Calcium Retention in the Adult Human Male As Affected by Protein  Intake.” Journal of
    Nutrition 102:1297-1302, 1972.
  119. Warmer, Rebecca, et al., Off Diabetes Pills, A Diabetic’s Guide to Longer Life. Public Citizens’ Health
    Group, Washington, 1978.
  120. Watanabe, Y., et a.:Chem. Pharm. Bull., 32, 3994, 1984: Shoji, K., et al.: ibid. 20, 1729, 1972:21, 308,
    1973: 25, 3049, 1977
  121. Weiss, R.F., Herbal Medicine. AB Arcanum, Gothenburg, Sweden, pp.275-278, 1988.
  122. Welihinda, J., et al., Effect of Momardica charantia on the Glucose Tolerance in Maturity Onset Diabetes. J Ethnopharmacol 17:277-282, 1986.
  123. Welihinda, J., et al., The Insulin-Releasing Activity of the Tropical Plant Momordica charantia. Acta Biol Med Germ 41:1229-1240, 1982.
  124. Whitaker, J.M., Reversing Diabetes. Warner Books, NY, 1987.
  125. Winterhoff, H., Gorkow, C., and Behr, B., Zeitschrift fur Phytotherapie12:175-179, 1991.
  126. Woongjin Health Book 2, Diabetes. Woongjin, Seoul, Korea, 1997.
  127. Yamahara, J., et al: Yakugaku zasshi, 101, 86,1973.
  128. Yoon, J.W., “Isolation of a Virus from the Pancreas of a Child with Ketocidosis.” New England Journal of Medicine 300:1173-1179, 1979